| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
58,256 |
51,653 |
$4.02M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,545 |
8,990 |
$1.82M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,769 |
2,416 |
$1.02M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,431 |
3,911 |
$1.00M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,093 |
2,063 |
$182K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,810 |
1,335 |
$135K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,878 |
5,668 |
$120K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,011 |
994 |
$89K |
| 36415 |
Collection of venous blood by venipuncture |
16,936 |
15,273 |
$79K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
563 |
540 |
$67K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
369 |
345 |
$57K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
762 |
743 |
$55K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
389 |
384 |
$53K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
937 |
911 |
$48K |
| 90834 |
Psychotherapy, 45 minutes with patient |
555 |
428 |
$41K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,786 |
6,176 |
$28K |
| 87631 |
|
1,186 |
1,162 |
$24K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
111 |
95 |
$20K |
| 96127 |
|
650 |
588 |
$19K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
669 |
605 |
$17K |
| 80053 |
Comprehensive metabolic panel |
3,103 |
2,944 |
$15K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
686 |
672 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,075 |
1,034 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,594 |
1,573 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
117 |
99 |
$8K |
| 90837 |
Psychotherapy, 53 minutes with patient |
49 |
43 |
$7K |
| 0002A |
|
495 |
483 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
111 |
106 |
$6K |
| 0001A |
|
492 |
481 |
$6K |
| 90686 |
|
868 |
841 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
717 |
564 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
217 |
198 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
89 |
78 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
74 |
70 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
162 |
149 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
162 |
149 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
44 |
40 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
69 |
25 |
$3K |
| 98927 |
|
130 |
113 |
$2K |
| 73630 |
|
35 |
28 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
111 |
105 |
$2K |
| 80061 |
Lipid panel |
161 |
154 |
$2K |
| 85610 |
|
1,179 |
475 |
$2K |
| 87070 |
|
91 |
86 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
240 |
229 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
48 |
30 |
$1K |
| 90791 |
Psychiatric diagnostic evaluation |
15 |
15 |
$1K |
| 81001 |
|
240 |
228 |
$1K |
| 90461 |
|
138 |
117 |
$1K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
14 |
12 |
$1K |
| 0004A |
|
67 |
60 |
$1K |
| 92552 |
|
12 |
12 |
$817.24 |
| 83690 |
|
39 |
38 |
$809.85 |
| 11721 |
|
44 |
37 |
$544.22 |
| 86850 |
|
39 |
36 |
$347.60 |
| 84484 |
|
14 |
14 |
$333.84 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
90 |
90 |
$291.51 |
| 83880 |
|
12 |
12 |
$279.38 |
| 90670 |
|
39 |
37 |
$245.98 |
| 92015 |
Determination of refractive state |
85 |
82 |
$119.18 |
| 97803 |
|
13 |
12 |
$105.43 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
13 |
$104.32 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13 |
12 |
$86.90 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
98 |
86 |
$78.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
136 |
106 |
$76.80 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$63.22 |
| 82248 |
|
79 |
74 |
$55.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
233 |
219 |
$38.93 |
| 83735 |
|
14 |
14 |
$36.39 |
| 86140 |
|
13 |
13 |
$11.62 |
| 83605 |
|
38 |
37 |
$0.00 |
| 85027 |
|
42 |
39 |
$0.00 |
| 91307 |
|
15 |
13 |
$0.00 |
| 85379 |
|
14 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
31 |
27 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
190 |
87 |
$0.00 |
| 81025 |
|
13 |
13 |
$0.00 |
| 91300 |
|
787 |
726 |
$0.00 |
| 90685 |
|
21 |
16 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
27 |
26 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
30 |
26 |
$0.00 |
| 87634 |
|
20 |
20 |
$0.00 |